January 2021

KPWHRI recently received word of 4 new awards.

Assisted Identification and Navigation of Early Mental Health Symptoms in Children:

A 4-year, $3,132,781 grant from the National Institute of Mental Health. Major goals: To conduct a pragmatic trial of early intervention (mental health navigation support supplemented by clinic-to-home telemental health services, when warranted) among children and youth 4-12 years of age. The Kaiser Permanente Washington Health Research Institute lead investigator is Robert Penfold.

Kaiser Permanente National Cancer Institute (NCI) National Community Oncology Research Program, NCI Community Oncology Research Program Renewal:

A 5-year, $324,996 grant from the NCI. Major goals: To develop the NCI National Community Oncology Research Program. The Kaiser Permanente Washington Health Research Institute lead investigator is Karen Wernli.

Moderna's External Safety Advisory Board (ESAB) for mRNA-1273:

A 1-year, $27,857 grant from ModernaTX, Inc. Major goals: The major aims of this project are to provide statistical expertise in vaccine safety as part of Moderna's External Safety Advisory Board (ESAB) for mRNA-1273 (their candidate COVID-19 vaccine), as Moderna prepares to receive an Emergency Use Authorization from the Food and Drug Administration (FDA).  The Kaiser Permanente Washington Health Research Institute lead investigator is Jennifer Nelson.

Vaccine Safety Datalink Project (VSD) COVID Participation- Request for Task Order Proposal:

A 3-year, $280,310 grant from the Centers for Disease Control and Prevention. Major goals: The purpose of this task order is for the contractors to contribute to the main functions of VSD COVID-19 vaccine safety activities. The work from this task order will support and contribute to the COVID-19 vaccine safety work of the VSD. The Kaiser Permanente Washington Health Research Institute lead investigator is Lisa Jackson.